BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28324002)

  • 1. Association of NAFLD With Diabetes and the Impact of BMI Changes: A 5-Year Cohort Study Based on 18,507 Elderly.
    Liu M; Wang J; Zeng J; Cao X; He Y
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1309-1316. PubMed ID: 28324002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
    Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
    Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
    Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
    JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
    Yilmaz Y; Senates E; Yesil A; Ergelen R; Colak Y
    J Diabetes Complications; 2014; 28(3):328-31. PubMed ID: 24602757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study.
    Wang M; Zhao Y; He Y; Zhang L; Liu J; Zheng S; Bai Y
    Nutr Metab Cardiovasc Dis; 2023 Aug; 33(8):1521-1528. PubMed ID: 37336719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects.
    Lee J; Cho YK; Kang YM; Kim HS; Jung CH; Kim HK; Park JY; Lee WJ
    Sci Rep; 2019 Nov; 9(1):17258. PubMed ID: 31754157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus.
    Yang LJ; Zhou JZ; Zheng YF; Hu X; He ZY; Du LJ; Gu X; Huang XY; Li J; Li YQ; Pan LY; Zhang XX; Gu XJ
    J Endocrinol Invest; 2023 Aug; 46(8):1565-1572. PubMed ID: 36725809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
    Du T; Yu X; Yuan G; Zhang J; Sun X
    Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
    Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
    J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
    Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
    Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
    Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of bedtime with the risk of non-alcoholic fatty liver disease among middle-aged and elderly Chinese adults with pre-diabetes and diabetes.
    Hu C; Zhang Y; Wang S; Lin L; Peng K; Du R; Qi H; Zhang J; Wang T; Zhao Z; Li M; Xu Y; Xu M; Li D; Bi Y; Wang W; Chen Y; Lu J
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3322. PubMed ID: 32268002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
    Ortiz-Lopez C; Lomonaco R; Orsak B; Finch J; Chang Z; Kochunov VG; Hardies J; Cusi K
    Diabetes Care; 2012 Apr; 35(4):873-8. PubMed ID: 22374640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease.
    Hossain IA; Akter S; Bhuiyan FR; Shah MR; Rahman MK; Ali L
    BMC Res Notes; 2016 May; 9():266. PubMed ID: 27169860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
    Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
    Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.
    Yamazaki H; Tsuboya T; Tsuji K; Dohke M; Maguchi H
    Diabetes Care; 2015 Sep; 38(9):1673-9. PubMed ID: 26156527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.